InvestSMART

Pro Medicus Limited (ASX:PME)

ALERT: Price-sensitive ASX Announcement for PME
Current share price for PME : $187.110 54.41 (41%)+
Announcement
Release
9 Mar 2026 8:19AM
Price at Release
$132.700
Full Release
download
Summary
Pro Medicus Limited, a leading health imaging company, announced that its U.S. subsidiary, Visage Imaging, Inc., has renewed two significant 5-year contracts totaling a minimum of A$40 million. The first contract is with MedStar Health, worth A$31 million, which includes the renewal of the full suite of Visage 7 modules and the addition of a new Cardiology Imaging module. The second contract is a A$9 million renewal with Zwanger-Pesiri, a large private outpatient radiology provider. Both contracts were negotiated with increased per transaction fees, offering potential upside. These renewals underscore the scalability and cloud-native advantages of Pro Medicus's enterprise imaging solutions.
Key Points
  • Pro Medicus Limited announces two 5-year contract renewals.
  • Contracts are worth a minimum of A$40 million in total.
  • A$31 million renewal with MedStar Health includes new Cardiology module.
  • A$9 million renewal with Zwanger-Pesiri.
  • Both renewals have increased per transaction fees.
  • Contracts provide potential upside based on transaction volume.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.